These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

943 related items for PubMed ID: 12365957

  • 21. Impact of health plan design and management on retirees' prescription drug use and spending, 2001.
    Thomas CP, Wallack SS, Lee S, Ritter GA.
    Health Aff (Millwood); 2002; Suppl Web Exclusives():W408-19. PubMed ID: 12703602
    [Abstract] [Full Text] [Related]

  • 22. Employers push to manage prescription drug costs.
    Frieden J.
    Bus Health; 1992 May; 10(6):43-6, 48, 50. PubMed ID: 10119119
    [No Abstract] [Full Text] [Related]

  • 23. Effect of Generic Competition on Atorvastatin Prescribing and Patients' Out-of-Pocket Spending.
    Luo J, Seeger JD, Donneyong M, Gagne JJ, Avorn J, Kesselheim AS.
    JAMA Intern Med; 2016 Sep 01; 176(9):1317-23. PubMed ID: 27367749
    [Abstract] [Full Text] [Related]

  • 24. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs.
    Fairman KA, Motheral BR, Henderson RR.
    Clin Ther; 2003 Dec 01; 25(12):3147-61; discussion 3144-6. PubMed ID: 14749153
    [Abstract] [Full Text] [Related]

  • 25. Effect of a three-tier prescription copay on pharmaceutical and other medical utilization.
    Motheral B, Fairman KA.
    Med Care; 2001 Dec 01; 39(12):1293-304. PubMed ID: 11717571
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Managing prescription drug costs.
    Sica JM.
    Empl Benefits J; 2001 Mar 01; 26(1):35-40. PubMed ID: 11272515
    [Abstract] [Full Text] [Related]

  • 29. Features of employment-based health plans.
    Fronstin P.
    EBRI Issue Brief; 1998 Sep 01; (201):1-21. PubMed ID: 10345788
    [Abstract] [Full Text] [Related]

  • 30. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS.
    Fed Regist; 2005 Jan 28; 70(18):4193-585. PubMed ID: 15678603
    [Abstract] [Full Text] [Related]

  • 31. Medicare Part D Payments for Topical Steroids: Rising Costs and Potential Savings.
    Song H, Adamson A, Mostaghimi A.
    JAMA Dermatol; 2017 Aug 01; 153(8):755-759. PubMed ID: 28453645
    [Abstract] [Full Text] [Related]

  • 32. Relationship of the use and costs of physician office visits and prescription drugs to travel distance and increases in member cost share.
    Cecil WT, Barnes J, Shea T, Coulter SL.
    J Manag Care Pharm; 2006 Oct 01; 12(8):665-76. PubMed ID: 17269845
    [Abstract] [Full Text] [Related]

  • 33. The effects of copayments and generic substitution on the use and costs of prescription drugs.
    Smith DG.
    Inquiry; 1993 Oct 01; 30(2):189-98. PubMed ID: 8314607
    [Abstract] [Full Text] [Related]

  • 34. Impacts of generic competition and benefit management practices on spending for prescription drugs: evidence from Medicare's Part D benefit.
    Sheingold S, Nguyen NX.
    Medicare Medicaid Res Rev; 2014 Oct 01; 4(1):. PubMed ID: 24918023
    [Abstract] [Full Text] [Related]

  • 35. Out-of-Pocket and Health Care Spending Changes for Patients Using Orally Administered Anticancer Therapy After Adoption of State Parity Laws.
    Dusetzina SB, Huskamp HA, Winn AN, Basch E, Keating NL.
    JAMA Oncol; 2018 Jun 14; 4(6):e173598. PubMed ID: 29121177
    [Abstract] [Full Text] [Related]

  • 36. Effects of an increase in prescription copayment on utilization of low-sedating antihistamines and nasal steroids.
    Meissner BL, Moore WM, Shinogle JA, Reeder CE, Little JM.
    J Manag Care Pharm; 2004 Jun 14; 10(3):226-33. PubMed ID: 15228372
    [Abstract] [Full Text] [Related]

  • 37. Patient and Payer Incentives to Use Patented Brand-Name Drugs vs Authorized Generic Drugs in Medicare Part D.
    Dusetzina SB, Sarpatwari A, Carrier MA, Hansen RA, Keating NL, Huskamp HA.
    JAMA Intern Med; 2021 Dec 01; 181(12):1605-1611. PubMed ID: 34661600
    [Abstract] [Full Text] [Related]

  • 38. Undocumented source of pharmacy benefit manager revenue.
    Siracuse MV, Clark BE, Garis RI.
    Am J Health Syst Pharm; 2008 Mar 15; 65(6):552-7. PubMed ID: 18319501
    [Abstract] [Full Text] [Related]

  • 39. Out-Of-Pocket Spending For Maternity Care Among Women With Employer-Based Insurance, 2008-15.
    Moniz MH, Fendrick AM, Kolenic GE, Tilea A, Admon LK, Dalton VK.
    Health Aff (Millwood); 2020 Jan 15; 39(1):18-23. PubMed ID: 31905056
    [Abstract] [Full Text] [Related]

  • 40. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
    Hwang TJ, Jain N, Lauffenburger JC, Vokinger KN, Kesselheim AS.
    JAMA Intern Med; 2019 Mar 01; 179(3):374-380. PubMed ID: 30640379
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 48.